Cingulate dynamics track depression recovery with deep brain stimulation.
Sankaraleengam Alagapan, Ki Sueng Choi, Stephen Heisig...
https://pubmed.ncbi.nlm.nih.gov/37730990/Actively Recruiting
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2026-04-27
5
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are studying personalized deep brain stimulation DBS to treat treatment-resistant depression by identifying the best brain targets using brain imaging and stereo-electroencephalography SEEG. The trial aims to find the optimal brain region and stimulation settings for each patient, understand neural markers of depression, and assess the safety and effectiveness of this personalized approach. This early-phase study is sponsored by the Second Affiliated Hospital, School of Medicine, Zhejiang University. The study has four phases. First, a 7-day preoperative phase includes symptom assessments and brain imaging. Next, during a 14-day SEEG phase, electrodes will be implanted to record brain activity. Then, the 421-day DBS treatment phase involves implanting a DBS device to provide electrical stimulation while patients complete depression assessments and follow-up visits every two weeks. Finally, a 2-month observation phase without stimulation will assess maintained effects if symptoms return, DBS will restart until study completion. Participants will undergo regular evaluations including depression rating scales such as the Hamilton Rating Scale for Depression HAMD, Montgomery-Asberg Depression Rating Scale MADRS, and others every two weeks during treatment and observation. Safety and adverse events will be monitored perioperatively and throughout the study. The trial will measure changes in depression scores from before treatment through the entire study period, lasting over 15 months.
CONDITIONS
Personalized DBS Targeting for Treating Depression
J
Junming Zhu, Ph.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 7 days
Participants complete preoperative symptom assessments, brain imaging, and task-state functional magnetic resonance imaging (fMRI) assessments.
Visits as needed during the 7-day period
Duration - 14 days
Participants are implanted with SEEG electrodes and complete a series of SEEG assessments, including intraoperative neurophysiological recordings and esketamine administration.
Visits throughout the 14-day period
Duration - 421 days
Participants receive deep brain stimulation treatment with implanted DBS devices and complete depressive symptom assessments along with follow-up visits.
Follow-up visits every 2 weeks during treatment
Duration - 2 months
Participants with good outcomes after DBS treatment have the electrical stimulation shut down for observation of treatment efficacy maintenance, with symptom assessments and follow-up visits. If symptoms rebound, DBS treatment may restart during this period.
Follow-up visits every 2 weeks during observation
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Sankaraleengam Alagapan, Ki Sueng Choi, Stephen Heisig...
https://pubmed.ncbi.nlm.nih.gov/37730990/Katherine W Scangos, Ankit N Khambhati, Patrick M Daly...
https://pubmed.ncbi.nlm.nih.gov/34608328/Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor